Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#768 in Seoul
#2,202 in South Korea
Medexgen Co., Ltd.
Forward Citations = 47
9 inventors:
Medexgen Co., Ltd.
% Expired Patents = 25.0
CIPO Patents = 1
EPO Patents = 1
Forward Citations = 47
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Yong-Hoon Chung (4 out of 5 patents)
Ji-Woong Han (3 out of 6 patents)
Hye-Ja Lee (3 out of 3 patents)
4. Jin-Mi Kim (3 out of 3 patents)
5. Eun-Yong Choi (3 out of 3 patents)
6. Ki-Wan Yi (1 out of 2 patents)
7. Hak-sup Lee (1 out of 1 patent)
8. Youn-Hwa Heo (1 out of 1 patent)
9. Jae-Youn Kim (1 out of 1 patent)
10. Hak-Sup Lee (0 patent)
4 patents:
Company Overview
Medexgen Co., Ltd. is a leading biotechnology company specializing in the development and commercialization of precision medicine solutions. With a focus on personalized healthcare, Medexgen utilizes genetic testing and advanced analytics to provide tailored treatment options for patients. Our innovative products and services are at the forefront of the healthcare industry, helping to improve outcomes and quality of life for individuals worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medexgen Co., Ltd.. Retrieved from https://idiyas.com/company/medexgen-company
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]